Publikationen in Zusammenarbeit mit Forschern von University of Paris-Sorbonne (7)

2024

  1. Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial

    American Heart Journal, Vol. 272, pp. 11-22

2023

  1. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT

    International Journal of Cardiology, Vol. 383, pp. 24-32

  2. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial

    American Journal of Cardiology, Vol. 208, pp. 16-24

  3. Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 20, pp. 2514-2524

2022

  1. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1948-1960

  2. Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection

    JAMA Cardiology, Vol. 7, Núm. 2, pp. 159-166

2021

  1. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis

    JACC: Cardiovascular Interventions, Vol. 14, Núm. 4, pp. 444-456